Contact this trialFirst, we need to learn more about you.
Endothelin Receptor Antagonist
Sitaxsentan for Pulmonary Arterial Hypertension
Recruiting1 awardPhase 2 & 3
New York, New York
This trial is testing a new medication, sitaxsentan, for the treatment of pulmonary arterial hypertension. The study will compare the safety and effectiveness of two different doses of sitaxsentan to placebo. Patients who complete the trial may be eligible to participate in an extension trial.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.